Clinical Trial Update: MicroRNA Mediates Volatile Anesthetics Preconditioning Induced Artery Protection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether microRNA mediates the protective effects of volatile anesthetics used during coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Liang Zhang | Conditions: Coronary Artery Bypass Graft Triple Vessel | Phase 4 | Status: UNKNOWN